Tavistock Life Sciences is a venture capital investment firm specialized in earl-stage investments.
Tavistock Group is an international private investment organization comprised of a family office, trading operation, and a portfolio of public investments and private companies. These investments are concentrated in nine primary sectors, including: real estate, hospitality, restaurants, sports, energy, retail, biotechnology and life sciences, agriculture, and finance.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 17, 2018
Avidity Biosciences
|
Series B | $16M | Biotechnology | — |
Nov 12, 2014
Blueprint Medicines
|
Series C | $50M | Bioinformatics | — |